Viropharma Inc's ROA from the third quarter of 2013 to the third quarter of 2012 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Viropharma Inc's ROA in the third quarter of 2013?
Viropharma Inc recorded a cumulative net loss of $-63 million during 12 months ending in the third quarter of 2013, resulting in a negative return on assets (ROA) of -5.49%.

However, within the Healthcare sector 208 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2013 from 3548 to 3590.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2013) III. Quarter	(Jun 30 2013) II. Quarter	(Mar 31 2013) I. Quarter	(Dec 31 2012) IV. Quarter	(Sep 30 2012) III. Quarter
Y / Y Total Assets Change	-8.48 %	-20.57 %	-17.58 %	-7.48 %	-0.39 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-63	-72	-77	9	43
Return On Assets (TTM)	-5.49 %	-6.12 %	-6.15 %	0.7 %	3.25 %
VPHM's Total Ranking	# 3590	# 3548	# 3481	# 2648	# 1195
Total Assets (TTM) in million	1,136	1,113	1,086	1,266	1,241
Seq. Total Assets Change	2.08 %	2.53 %	-14.24 %	1.97 %	-11.41 %
Seq. Net Income Change	600 %	-	-	-	-

VPHM's 5 Years Annual ROA >> Back to VPHM Management Effectiveness >> Compare VPHM ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 23
Sector	# 209
Overall	# 2933

Return On Assets Statistics
High	Average	Low
8.77 %	0.05 %	-6.18 %
(Mar 31 2012)		(Mar 31 2013)

Financial Statements
Viropharma Inc's Assets	$ 1,136 million	VPHM's Balance sheet
Viropharma Inc's Income	$ 4 million	Quarterly VPHM's Income Statement
VPHM's Income by Division		See VPHM's Income by Division

Annual Return On Assets	(Dec 31 2012) FY 2012	(Dec 31 2009) FY 2011	FY	FY	FY
Y / Y Total Assets Change	-7.59 %	-	-	-	-
Total Assets in million	1,220	1,320	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	6	-11	0	0	0
Annual Return On Assets	0.46 %	-0.84 %	-	-	-

VPHM's 5 Years Annual ROA >> Back to VPHM Management Effectiveness >> Compare VPHM ROA to its Competitors

Comment on VPHM's ROA in the fiscal year ending 2012

In the fiscal year 2012 ROA improved to 0.46 % compared to prior year, due to annual net income growth of % to $5.61 million, and due to decline of value in Viropharma Inc's assets by -7.59 % to $1,219.95 million, compared to $1,219.95 a year before.

More Return On Assets Ratios
VPHM's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VPHM's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VPHM's Competitors
Subscribers only: Roa for Viropharma Inc's Suppliers
Subscribers only: Return On Assets for VPHM's Customers

You may also want to know
VPHM's Roi	VPHM's Inventory Turnover Ratio	VPHM's Growth Rates	VPHM's Dividend Comparisons
	VPHM's Profitability Ratios	VPHM's Asset Turnover Ratio	VPHM's Dividend Growth
VPHM's Roe	VPHM's Valuation Ratios	VPHM's Financial Strength Ratios	VPHM's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2013, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:07:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.